you are here: HomeNewsIndia

Kerala logs 1,412 new COVID-19 cases, active cases touch 39,236

In the 24 hours ending 2 pm, 39,046 samples had been tested and the test positivity rate was 3.62 percent.

March 08, 2021 / 07:46 PM IST

Kerala reported 1,412 fresh COVID-19 cases on Monday, while 3,030 people have recovered from the infection, with the active cases in the state touching 39,236, the government said.

While the total virus caseload soared to 10,79,088, as many as 10,34,895 people have been cured of the disease, Health minister K K Shailaja said in a press release. It said a South African returnee was among those who tested positive for the virus.

In the 24 hours ending 2 pm, 39,046 samples had been tested and the test positivity rate was 3.62 percent.

According to the release, 1,19,31,921 samples have been sent for testing so far.

Kozhikode accounted for 245 fresh cases today, Kollam 141, Thiruvananthapuram 139 and Ernakulam138. The release said 98 people who have returned from the UK and two from South Africa have tested positive for the infection so far. Of these, 83 have recovered.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

At least 11 people were found with the new variant of the virus,it said.

Samples of at least 12 people, who passed away recently, have tested positive for the virus, taking the total fatalities to 4,312.

Of those who tested positive today, six are health workers, 37 had come from outside the state and 1,252 had been infected through contact.

As many as 1,68,505 people are under observation in various districts, including 5512 in various hospitals.

There are 356 hotspots in the state.

Follow our full coverage of the coronavirus pandemic here.
first published: Mar 8, 2021 07:45 pm

stay updated

Get Daily News on your Browser